8.25.14 Base Pair Biotechnologies has been awarded another Phase 1 SBIR contract to develop aptamers to cytomegalovirus proteins in urine and saliva for “Rapid Point-of-Care Tests for Cytomegalovirus” from the Centers for Disease Control (CDC). Principal Investigator on the project will be Mark Morris, Ph.D. Senior Scientist, Base Pair Biotechnologies, Inc.

Discover more from Base Pair Biotechnologies

Subscribe now to keep reading and get access to the full archive.

Continue reading